Cerebrovascular reactivity is the change in cerebral blood flow in response to a vaso-active stimulus. Overview CVR requires a subject to inhale a mixture of air & carbon dioxide. Inhaling this mixture induces hypercapnia & causes vasodilation. It is a well-documented method of measuring CVR. Purpose To determine if various imaging methods are sensitive & practical enough to use in early phase clinical trials of interventions to prevent progressive small vessel disease. Patient data pertaining to CVR is currently limited. Our research is designed to: Determine feasibility & to compare CVR with retinal vasoreactivity & measures of peripheral vascular health Provide proof of principle Determine sample size requirements prior to phase 2 trials & mechanistic studies. Detail Prior to MR scanning, the subject undergoes retinal imaging, both before & after the induced hypercapnia. Retinal imaging allows measurement of retinal vascular reactivity & can be correlated with CVR. During the MR scan which follows, the subject undergoes hypercapnia again. MR allows measurement of CVR in grey matter, white matter, & in white matter hyperintensities. Blood Oxygen Level Dependent (BOLD) sequences allow measurement of the CVR. The subject also undergoes structural imaging, plus flow sensitive scans of the cerebral aqueduct, venous sinuses & carotid arteries. The subject then undergoes Doppler ultrasound in order to capture flow measurements of the internal & common carotid arteries. Finally, pulse wave analysis test & pulse wave velocity measurement are carried out using the SphygmoCor system. Subjects are being scanned on both the 1.5T MR scanner at the Edinburgh Imaging Facility WGH & the 3T MR scanner at the Edinburgh Imaging Facility RIE. Contact Dr Michael Thrippleton This article was published on 2024-08-22